Phylos Bioscience

OrganiGram Holdings Inc (NASDAQ:OGI), a Canadian cannabis operator producer, has increased its investment in Phylos Bioscience Inc., a U.S.-based cannabis genetics company. Following the achievement of a crucial milestone under their May 2023 loan agreement, Organigram has closed the second tranche...

In 1970, University of Oxford researchers unveiled the discovery of tetrahydrocannabivarin (THCV), a unique cannabis compound distinct from the well-known THC and CBD. For decades, its elusive nature conferred it a legendary status, earning denominations like “the sports car of weed” or...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands. The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has reached agreement with Phylos Bioscience Inc., to initiate a wide-ranging technical and commercial relationship in Canada. This innovation relationship is expected to further support Organigram’s cultivation efforts in Canada with patent-...

Six cannabis executives made their pitch to investors last week at the Benzinga Cannabis Capital Conference in Chicago. MariMed Bob Fireman, CEO and president of Marimed Inc (OTC: MRMD), began his presentation by highlighting the industry's responsibility to patients and their medical...